Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
Status:
Completed
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare active immunotherapy (OPT-822/OPT-821) with PBS in
combination with low dose cyclophosphamide, in post-treated metastatic breast cancer subjects
with stable disease or response to treatment.